The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Countries: The Case of Tanzania

Show simple item record

dc.contributor.author Mori, A. T
dc.contributor.author Kaale, E. A
dc.contributor.author Ngalesoni, F
dc.contributor.author Norheim, O. F
dc.contributor.author Robberstad, B
dc.date.accessioned 2015-10-19T07:49:37Z
dc.date.available 2015-10-19T07:49:37Z
dc.date.issued 2013
dc.identifier.citation Mori, A. T., Kaale, E. A., Ngalesoni, F., Norheim, O. F., & Robberstad, B. (2014). The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania. PloS one, 9(1), e84824. en_GB
dc.identifier.uri http://hdl.handle.net/123456789/1678
dc.description.abstract Background: Insufficient access to essential medicines is a major health challenge in developing countries. Despite the importance of Standard Treatment Guidelines and National Essential Medicine Lists in facilitating access to medicines, little is known about how they are updated. This study aims to describe the process of updating the Standard Treatment Guidelines and National Essential Medicine List in Tanzania and further examines the criteria and the underlying evidence used in decision-making. Methods: This is a qualitative study in which data were collected by in-depth interviews and document reviews. Interviews were conducted with 18 key informants who were involved in updating the Standard Treatment Guidelines and National Essential Medicine List. We used a thematic content approach to analyse the data. Findings: The Standard Treatment Guidelines and National Essential Medicine List was updated by committees of experts who were recruited mostly from referral hospitals and the Ministry of Health and Social Welfare. Efficacy, safety, availability and affordability were the most frequently utilised criteria in decision-making, although these were largely based on experience rather than evidence. In addition, recommendations from international guidelines and medicine promotions also influenced decision-making. Cost-effectiveness, despite being an important criterion for formulary decisions, was not utilised. Conclusions: Recent decisions about the selection of essential medicines in Tanzania were made by committees of experts who largely used experience and discretionary judgement, leaving evidence with only a limited role in decision-making process. There may be several reasons for the current limited use of evidence in decision-making, but one hypothesis that remains to be explored is whether training experts in evidence-based decision-making would lead to a better and more explicit use of evidence. en_GB
dc.language.iso en en_GB
dc.relation.ispartofseries PloS one,9(1), e84824;
dc.subject Decision-Making en_GB
dc.subject Evidence en_GB
dc.subject Medicine en_GB
dc.subject Developing Countries en_GB
dc.subject Role en_GB
dc.subject Tanzania en_GB
dc.title The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Countries: The Case of Tanzania en_GB
dc.type Article en_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search MUHAS IR


Advanced Search

Browse

My Account